ES2132284T3 - Derivados de carbamato de 2-(piperidin-4-il, piridin-4-il y tetrahidropiridin-4-il)-benzofurano-7, su preparacion y su uso como inhibidores de acetilcolinesterasa. - Google Patents
Derivados de carbamato de 2-(piperidin-4-il, piridin-4-il y tetrahidropiridin-4-il)-benzofurano-7, su preparacion y su uso como inhibidores de acetilcolinesterasa.Info
- Publication number
- ES2132284T3 ES2132284T3 ES94111962T ES94111962T ES2132284T3 ES 2132284 T3 ES2132284 T3 ES 2132284T3 ES 94111962 T ES94111962 T ES 94111962T ES 94111962 T ES94111962 T ES 94111962T ES 2132284 T3 ES2132284 T3 ES 2132284T3
- Authority
- ES
- Spain
- Prior art keywords
- loweralkyl
- hydrogen
- arylloweralkyl
- piperidin
- inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/86—Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
2-(PIPERIDIN-4-IL, PIRIDIN-4-IL Y TETRAHIDROPIRIDIN-4-IL) BENZOFURANO-7-OL Y DERIVADOS CARBAMATO DE LA FORMULA I EN DONDE R1 ES HIDROGENO, ALQUILO INFERIOR, ARIL ALQUILO INFERIOR, CONHR6 O CONR6R7, R2 ES HIDROGENO, CIANO, CH2NR8R9, CONHR5 O CONR6R7; DONDE R10 ES HIDROGENO, ALQUILO INFERIOR, ARIL ALQUILO INFERIOR, CONHR5, CONR6R7, ACILO, ACILOXIL ALQUILO INFERIOR O ACILOXILARIL ALQUILO INFERIOR; R4 ES HIDROGENO, HALOGENO, ALQUILO INFERIOR O ALCOXILO INFERIOR; R5 ES HIDROGENO, ALQUILO INFERIOR O ARIL ALQUILO INFERIOR; R6 ES ALQUILO INFERIOR O ARIL ALQUILO INFERIOR; R7 ES ALQUILO INFERIOR O ARIL ALQUILO INFERIOR; R8 ES HIDROGENO, ALQUILO INFERIOR, ARIL ALQUILO INFERIOR O ACILO; R9 ES HIDROGENO, ALQUILO INFERIOR O ARIL ALQUILO INFERIOR; R11 ES ALQUILO INFERIOR, ARILO O ARIL ALQUILO INFERIOR; CON LA PROVISION DE QUE SI R1 ES HIDROGENO O ALQUILO INFERIOR, R2 NO PUEDE SER HIDROGENO; O UNA SAL DE ADICION ACIDA FARMACEUTICAMENTE ACEPTABLE DE ELLOS, O DONDE SEA APLICABLE, UN ISOMERO GEOMETRICO U OPTICO O MEZCLAS RACEMICAS DE ELLOS, LOS CUALES SE USAN COMO INHIBIDORES DE ACETILCOLINESTERASA Y TAL COMO PUEDEN SER USADOS PARA EL TRATAMIENTO DEL MAL DE ALZHEIMER Y OTRAS DEMENCIAS SENILES.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10268193A | 1993-08-05 | 1993-08-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2132284T3 true ES2132284T3 (es) | 1999-08-16 |
Family
ID=22291102
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES94111962T Expired - Lifetime ES2132284T3 (es) | 1993-08-05 | 1994-08-01 | Derivados de carbamato de 2-(piperidin-4-il, piridin-4-il y tetrahidropiridin-4-il)-benzofurano-7, su preparacion y su uso como inhibidores de acetilcolinesterasa. |
Country Status (9)
Country | Link |
---|---|
US (1) | US5708007A (es) |
EP (1) | EP0637586B1 (es) |
JP (1) | JP2714536B2 (es) |
AT (1) | ATE180780T1 (es) |
CA (1) | CA2129462A1 (es) |
DE (1) | DE69418789T2 (es) |
DK (1) | DK0637586T3 (es) |
ES (1) | ES2132284T3 (es) |
GR (1) | GR3030798T3 (es) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5925636A (en) * | 1996-05-20 | 1999-07-20 | Darwin Discovery Limited | Benzofuran carboxamides and their therapeutic use |
TW555759B (en) | 1998-06-08 | 2003-10-01 | Darwin Discovery Ltd | Heterocyclic compounds and their therapeutic use |
KR100639543B1 (ko) | 1998-09-30 | 2006-10-31 | 다케다 야쿠힌 고교 가부시키가이샤 | 방광 배출력 개선제 |
KR100579813B1 (ko) * | 2001-10-16 | 2006-05-12 | 주식회사 에스티씨나라 | 피페리딘 유도체, 이의 제조방법 및 이를 포함하는 치매치료용 약학적 조성물 |
US20070088601A1 (en) * | 2005-04-09 | 2007-04-19 | Hirevue | On-line interview processing |
ES2790358T3 (es) | 2011-12-28 | 2020-10-27 | Global Blood Therapeutics Inc | Compuestos de heteroaril aldehído sustituido y métodos para su uso en el aumento de la oxigenación tisular |
PL3738434T3 (pl) | 2011-12-28 | 2024-03-04 | Global Blood Therapeutics, Inc. | Związki pośrednie do otrzymywania podstawionych związków benzaldehydowych i sposoby ich zastosowania do zwiększania natlenienia tkanek |
US10266551B2 (en) | 2013-03-15 | 2019-04-23 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
WO2014145040A1 (en) | 2013-03-15 | 2014-09-18 | Global Blood Therapeutics, Inc. | Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation |
CA2902711C (en) | 2013-03-15 | 2021-07-06 | Global Blood Therapeutics, Inc. | Substituted pyridinyl-6-methoxy-2-hydroxybenzaldehyde derivatives and pharmaceutical compositions thereof useful for the modulation of hemoglobin |
US9458139B2 (en) | 2013-03-15 | 2016-10-04 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
US8952171B2 (en) | 2013-03-15 | 2015-02-10 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
KR20190041548A (ko) | 2013-03-15 | 2019-04-22 | 글로벌 블러드 테라퓨틱스, 인크. | 헤모글로빈 조정을 위한 화합물 및 이의 용도 |
US20140274961A1 (en) | 2013-03-15 | 2014-09-18 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
CN105073728A (zh) | 2013-03-15 | 2015-11-18 | 全球血液疗法股份有限公司 | 化合物及其用于调节血红蛋白的用途 |
US9802900B2 (en) | 2013-03-15 | 2017-10-31 | Global Blood Therapeutics, Inc. | Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin |
US9422279B2 (en) | 2013-03-15 | 2016-08-23 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
EA202092627A1 (ru) | 2013-11-18 | 2021-09-30 | Глобал Блад Терапьютикс, Инк. | Соединения и их применения для модуляции гемоглобина |
PE20160179A1 (es) | 2014-02-07 | 2016-05-20 | Global Blood Therapeutics Inc | Polimorfos cristalinos de la base libre de 2-hidroxi-6-((2-(1-isopropil-1h-pirazol-5-il)piridin-3-il)metoxi)benzaldehido |
MA41841A (fr) | 2015-03-30 | 2018-02-06 | Global Blood Therapeutics Inc | Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs |
TW201731509A (zh) | 2015-12-04 | 2017-09-16 | 全球血液治療公司 | 針對2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之劑量方案 |
AR108435A1 (es) | 2016-05-12 | 2018-08-22 | Global Blood Therapeutics Inc | Proceso para sintetizar 2-hidroxi-6-((2-(1-isopropil-1h-pirazol-5-il)-piridin-3-il)metoxi)benzaldehído |
TWI778983B (zh) | 2016-10-12 | 2022-10-01 | 美商全球血液治療公司 | 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑 |
WO2020072377A1 (en) | 2018-10-01 | 2020-04-09 | Global Blood Therapeutics, Inc. | Modulators of hemoglobin for the treatment of sickle cell disease |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH592656A5 (es) * | 1973-03-02 | 1977-10-31 | Ciba Geigy Ag | |
US4600719A (en) * | 1973-03-02 | 1986-07-15 | Ciba Geigy Corporation | Tetrahydropyridine and piperidine derivatives |
CH609054A5 (en) * | 1975-11-26 | 1979-02-15 | Ciba Geigy Ag | Process for the preparation of a novel piperidine derivative |
EP0006524A1 (de) * | 1978-06-22 | 1980-01-09 | Ciba-Geigy Ag | Neue Tetrahydropyridin- und Piperidinderivate und deren Säureadditionssalze, Verfahren zu deren Herstellung und solche enthaltende pharmazeutische Zusammensetzungen |
US4863958A (en) * | 1984-06-20 | 1989-09-05 | Merck Frosst Canada, Inc. | Benzofuran derivatives useful as inhibitors of mammalian leukotriene biosynthesis |
CA1281325C (en) * | 1984-06-20 | 1991-03-12 | Patrice C. Belanger | Benzofuran derivatives |
US4659717A (en) * | 1985-08-21 | 1987-04-21 | Eli Lilly And Company | Dihydropyridines useful in the treatment of angina and stroke |
IL83275A (en) * | 1986-09-08 | 1994-02-27 | Novo Nordisk As | Compounds 1,2, 4-Oxadiazolyl Pipridine Transformed, their preparation and pharmaceutical preparations containing them |
FI95572C (fi) * | 1987-06-22 | 1996-02-26 | Eisai Co Ltd | Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi |
EP0398413A1 (en) * | 1989-05-16 | 1990-11-22 | Duphar International Research B.V | "3,4-dehydropiperidine derivatives having psychotropic activity |
JP2807577B2 (ja) * | 1990-06-15 | 1998-10-08 | エーザイ株式会社 | 環状アミド誘導体 |
RU2095339C1 (ru) * | 1991-10-17 | 1997-11-10 | Циба-Гейги АГ | Производные гидрохинона в свободном виде или в виде соли, способы их получения, производные пиперидина и способы их получения |
-
1994
- 1994-08-01 EP EP94111962A patent/EP0637586B1/en not_active Expired - Lifetime
- 1994-08-01 ES ES94111962T patent/ES2132284T3/es not_active Expired - Lifetime
- 1994-08-01 DK DK94111962T patent/DK0637586T3/da active
- 1994-08-01 DE DE69418789T patent/DE69418789T2/de not_active Expired - Fee Related
- 1994-08-01 AT AT94111962T patent/ATE180780T1/de not_active IP Right Cessation
- 1994-08-04 CA CA002129462A patent/CA2129462A1/en not_active Abandoned
- 1994-08-04 JP JP6183733A patent/JP2714536B2/ja not_active Expired - Fee Related
-
1996
- 1996-08-27 US US08/703,843 patent/US5708007A/en not_active Expired - Fee Related
-
1999
- 1999-07-20 GR GR990401886T patent/GR3030798T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
US5708007A (en) | 1998-01-13 |
CA2129462A1 (en) | 1995-02-06 |
GR3030798T3 (en) | 1999-11-30 |
DK0637586T3 (da) | 1999-12-06 |
DE69418789D1 (de) | 1999-07-08 |
DE69418789T2 (de) | 1999-12-02 |
EP0637586B1 (en) | 1999-06-02 |
JPH07109275A (ja) | 1995-04-25 |
EP0637586A1 (en) | 1995-02-08 |
ATE180780T1 (de) | 1999-06-15 |
JP2714536B2 (ja) | 1998-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2132284T3 (es) | Derivados de carbamato de 2-(piperidin-4-il, piridin-4-il y tetrahidropiridin-4-il)-benzofurano-7, su preparacion y su uso como inhibidores de acetilcolinesterasa. | |
NO903851D0 (no) | Fremgangsmaate for fremstilling av n-substituerte-4-pyrimidinaminer og -pyrimidindiaminer, og deres anvendelse som medikamenter. | |
NO941052L (no) | Benzimidazolforbindelser, deres anvendelse og fremstilling | |
NO873568L (no) | Alfa-alkyl-4-amino-kinolinmetanoler og 1-(4-aralkylamino-3-kinolinyl)alkanoler, samt fremgangsmaate for fremstilling derav. | |
DE68914292D1 (de) | Zusammensetzung zur Behandlung von ischämischen Störungen in Organen. | |
DK0474580T3 (da) | Anvendelse af 1-(3-dimethylamino)propyl)-1-phenylphthalener til behandling af cerebrovaskulære sygdomme | |
DK132188A (da) | Anvendelse af tetrahydrobenz(c,d)indol-6-carboxamider som anxiolytika | |
KR960704878A (ko) | 광학 활성 이미다졸리딘온 유도체 및 이의 제조방법 (Optically active imidazolidinone derivative and process for producing the same) | |
NO941516L (no) | 3-kinolylsubstituerte dihydropyridiner, fremgangsmåter for deres fremstilling og deres anvendelse | |
DE69319939T2 (de) | Aminobenzoesäure Derivate | |
DE69110219D1 (de) | 3-(1H-Indazol-3-yl)-4-pyridiname, Verfahren und Zwischenprodukte zu ihrer Herstellung und ihre Verwendung als Arzneimittel. | |
DE69114405D1 (de) | 3-(1,2-Benzisoxazol-3-yl)-4-Pyridinamine und Derivate. | |
ATE283269T1 (de) | 5-(heteroaryl)alkyl)-3-oxo-pyrido(1,2- a)benzimidazol-4-carboxamid (pbi) derivate zur behandlung von störungen des zentralen nervensystems | |
ATE130002T1 (de) | 1-(pyridinylalkyl)-1h-indole, -indoline und analoge. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 637586 Country of ref document: ES |